Month: May 2020

Stanford technology helps advance CRISPR-based cancer therapy A team led by Howard Chang has contributed key technology to enable new experimental cancer therapy that uses CRISPR to edit immune cells. Author Hanae ArmitagePublished on February 6, 2020February 6, 2020 Since the discovery of powerful gene-editing tool CRISPR-Cas9, scientists and physicians have awaited the day it
0 Comments
Improving cancer prognoses: A radio show A Stanford oncologist discusses how to improve cancer diagnosis and treatment, including using predictive modeling, liquid biopsies and immunotherapy. Author Jennifer HuberPublished on February 28, 2020February 27, 2020 “Looking in the patients’ eyes and having a conversation” has motivated Stanford oncologist Ash Alizadeh, MD, PhD, to improve the way
0 Comments
Cracking cancer’s code: Stanford Medicine magazine reports on treatments and developments Learn about chemo brain and what’s new in cancer treatment, research and education in Stanford Medicine magazine’s new issue highlighting the disease. Author Rosanne SpectorPublished on April 13, 2020April 21, 2020 What causes chemo brain? How can a smart toilet help detect cancer? And
0 Comments
Five years later: Lucy Kalanithi on loss, grief and love Stanford physician Lucy Kalanithi opens up about loss, grief and love for her neurosurgeon husband, Paul, five years after his death from lung cancer. Author Paul CostelloPublished on April 20, 2020April 22, 2020 Paul Kalanithi, MD, the Stanford Medicine neurosurgeon who wrote When Breath Becomes
0 Comments
Outsmarting cancer: Innovative treatments and diagnostics offer new hope Stanford researchers are devising new ways to tackle cancer through better, more sophisticated diagnostics and treatments. Author Hanae ArmitagePublished on April 30, 2020April 29, 2020 Researchers at Stanford Medicine are thinking up new ways to tackle one of the world’s most daunting diseases: cancer. My colleague
0 Comments
This content originally appeared on Beyond Type 1. Republished with permission. By Beyond Type 1 Editorial Team Feeling helpless in the midst of COVID-19? You’re not alone. There’s a lot we still don’t know about the virus and the situation is changing by the hour. One important thing to think about is separating what you
0 Comments
Tracey D. Brown is the Chief Executive Office (CEO) of the American Diabetes Association (ADA), a powerhouse organization in diabetes advocacy and research into prevention and treatment. She also lives with type 2 diabetes. Today, on her birthday, we reflect on her hard work, leadership and accomplishments in striving to improve the lives of people
0 Comments
This content originally appeared on Caroline’s Keto Kitchen. Republished with permission. Keto Candy Girl just started selling their Lemon Mix again, and I was pumped to see this because it’s my favorite mix of theirs! Thankfully shortly after they stopped selling it, Lolli’s came out with Lemon Drop Cookie Clusters, and these totally satisfied my lemon craving. Then
0 Comments
Researchers have found a new method that could help detect autism spectrum disorder months or even years before symptoms appear. Earlier diagnosis of the condition could help children get interventions earlier and avoid problems like social and communication challenges. The current approach to identify autism mainly relies on behavior. Existing blood or genetic tests in some
0 Comments
A minimally invasive multicancer blood test used with standard-of-care screening is safe, effective, and feasible for use in routine clinical care, according to interim findings from a large, prospective study. The DETECT-A blood test, an early version of the CancerSEEK test currently in development, effectively guided patient management in real time, in some cases leading
0 Comments
This is the sixth story in a series by MedPage Today examining the impact of COVID-19 on vulnerable populations. Past stories reported on the homeless, immigrants in detention, the undocumented, nursing home residents, and incarcerated individuals. With limited national data available to track COVID-19 outcomes by race, states and local municipalities started releasing their own
0 Comments
Kudos, the award-winning service for accelerating research impact, has today announced that it is opening up its leading research communications platform – Kudos Pro – to the global academic community, with complimentary access for 60 days. Over 2,000 researchers around the world have already signed up for complimentary access following an exclusive pre-launch. With campuses
0 Comments
Print this page KENILWORTH, N.J.–(BUSINESS WIRE) April 28, 2020 –Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved an additional recommended dosage of 400 mg every six weeks (Q6W) for Keytruda, Merck’s anti-PD-1 therapy, across all adult indications, including monotherapy
0 Comments
QT interval prolongation remained a safety concern with hydroxychloroquine (HCQ) for COVID-19 in reports from Boston and France, highlighting the need for careful monitoring. Risk was particularly elevated when HCQ was administered with azithromycin in both studies, published online in JAMA Cardiology. Both agents have been known to be mechanistically capable of extending the QT
0 Comments